Abstract

ObjectivesTo evaluate the effect of certolizumab pegol (CZP) on work and household productivity, and on participation in family, social and leisure activities in patients with axial spondyloarthritis (axSpA), including ankylosing...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study
D Gladman ... D Van Der Heijde
Annals of the Rheumatic Diseases | VOL. 74
D Gladman, et. al.D Gladman ... D Van Der Heijde
18 Jun 2014
OP0107 Improvements in Work and Household Productivity after 24 Weeks of Certolizumab Pegol in Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of Rapid-Axspa Study
A Kavanaugh ... O Purcaru
Annals of the Rheumatic Diseases | VOL. 72
A Kavanaugh, et. al.A Kavanaugh ... O Purcaru
01 Jun 2013
SAT0389 Long-Term Improvements in Workplace and Household Productivity and Social Participation over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
R Landewé ... O Purcaru
Annals of the Rheumatic Diseases | VOL. 75
R Landewé, et. al.R Landewé ... O Purcaru
01 Jun 2016
THU0202 Clinical Responses and Improvements in Patient-reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
...
Annals of the Rheumatic Diseases | VOL. 74
, et. al. ...
01 Jun 2015
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort
Jacopo Ciaffi ... Eustar Collaborators
RMD Open | VOL. 10
Jacopo Ciaffi, et. al.Jacopo Ciaffi ... Eustar Collaborators
20 May 2024
Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence
Noémie Théate ... Jean-Hugues Salmon
RMD Open | VOL. 10
Noémie Théate, et. al.Noémie Théate ... Jean-Hugues Salmon
20 May 2024
Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies
Grégoire Martin De Frémont ... Jérome Hadjadj
RMD Open | VOL. 10
Grégoire Martin De Frémont, et. al.Grégoire Martin De Frémont ... Jérome Hadjadj
20 May 2024
Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid
Carlos Raúl Ramírez Medina ... Meghna Jani
RMD Open | VOL. 10
Carlos Raúl Ramírez Medina, et. al.Carlos Raúl Ramírez Medina ... Meghna Jani
20 May 2024
View more papers